Literature DB >> 12565837

Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.

Kazuyuki Takata1, Yoshihisa Kitamura, Jun-ichi Kakimura, Keiichi Shibagaki, Daiju Tsuchiya, Takashi Taniguchi, Mark A Smith, George Perry, Shun Shimohama.   

Abstract

In Alzheimer's disease (AD), fibrillar amyloid-beta (Abeta) peptides form senile plaques associated with activated microglia. Recent studies have indicated that microglial Abeta clearance is facilitated by several activators such as transforming growth factor-beta1 (TGF-beta1). The relationship between microglia and Abeta formation and deposition is still unclear. In the present study, high mobility group protein-1 (HMG1) inhibited the microglial uptake of Abeta (1-42) in the presence and absence of TGF-beta1. In addition, HMG1 bound to Abeta (1-42) and stabilized the oligomerization. In AD brains, protein levels of HMG1 were significantly increased in both the cytosolic and particulate fractions, and HMG1 and Abeta were colocalized in senile plaques associated with microglia. These results suggest that HMG1 may regulate the homeostasis of extracellular Abeta (1-42) and Abeta oligomerization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565837     DOI: 10.1016/s0006-291x(03)00024-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.

Authors:  Bing Sun; Pranjali Dalvi; Linda Abadjian; Norina Tang; Lynn Pulliam
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

Review 2.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 4.  High-mobility group protein box-1 and its relevance to cerebral ischemia.

Authors:  Qing-wu Yang; Jing-Zhou Wang; Jing-Cheng Li; Yu Zhou; Qi Zhong; Feng-Lin Lu; Jing Xiang
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

Review 5.  HMGB1 in development and diseases of the central nervous system.

Authors:  Ping Fang; Melitta Schachner; Yan-Qin Shen
Journal:  Mol Neurobiol       Date:  2012-05-13       Impact factor: 5.590

6.  Microglial Amyloid-β1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer's Disease.

Authors:  Kazuyuki Takata; Tetsuya Takada; Aina Ito; Mayo Asai; Manami Tawa; Yuki Saito; Eishi Ashihara; Hidekazu Tomimoto; Yoshihisa Kitamura; Shun Shimohama
Journal:  Int J Alzheimers Dis       Date:  2012-05-08

Review 7.  NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity.

Authors:  Valeria Bortolotto; Bruna Cuccurazzu; Pier Luigi Canonico; Mariagrazia Grilli
Journal:  Biomed Res Int       Date:  2014-02-12       Impact factor: 3.411

8.  Protective effects of curcumin against neuroinflammation induced by Aβ25-35 in primary rat microglia: modulation of high-mobility group box 1, toll-like receptor 4 and receptor for advanced glycation end products expression.

Authors:  Wei He; Kaiming Yuan; Bin Ji; Yuan Han; Jun Li
Journal:  Ann Transl Med       Date:  2020-02

9.  Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage.

Authors:  Xiang-Dong Zhu; Jing-Sen Chen; Feng Zhou; Qi-Chang Liu; Gao Chen; Jian-Min Zhang
Journal:  J Neuroinflammation       Date:  2012-08-11       Impact factor: 8.322

10.  Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.

Authors:  Guan-Ting Liu; Chi-Shin Hwang; Chia-Hung Hsieh; Chih-Hao Lu; Sunny Li-Yun Chang; Jin-Ching Lee; Chien-Fu Huang; Hao-Teng Chang
Journal:  Mediators Inflamm       Date:  2013-02-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.